T
TNYA
Tenaya Therapeutics, Inc.
0.6600
-0.0346-4.98%After Hours: 0.7000 +0.0400 +6.06%19:41 04/06 EDT
OPEN/PREV CLOSE0.6900/0.6676
TODAY RANGE0.6899-0.7285
VOL3.70M
MARKET CAP157.37M
52 WEEK RANGE0.3600-2.350
AVG VOL (3M)4.42M
% TURNOVER1.71%
TURNOVER--
P/E (TTM)-1.2246
% RANGE5.78%
EPS(TTM)-0.5922
P/E(FORWARD)-1.5765
P/B1.275
BVPS0.5687
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP156.19M
SHARES OUTSTANDING217.00M
NEXT EARNINGS05/01-05/13
FREE FLOAT215.37M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Benzinga·03/24 12:05
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Simply Wall St·03/14 01:36
How TN-301 Progress And Alnylam Deal At Tenaya Therapeutics (TNYA) Has Changed Its Investment Story
Simply Wall St·03/12 20:18
Tenaya Therapeutics (TNYA) Valuation After TN-301 Data And New Alnylam Collaboration
Dow Jones·03/12 12:38
Tenaya Therapeutics Price Target Maintained With a $8.00/Share by Chardan Capital
Dow Jones·03/12 12:38
Tenaya Therapeutics Is Maintained at Buy by Chardan Capital
Reuters·03/11 20:37
Tenaya Therapeutics' Q4 net loss narrows, extends cash runway into H2 2027
TipRanks·03/11 20:27
Tenaya Therapeutics reports Q4 EPS (12c), consensus (12c)
Benzinga·03/11 20:10
Tenaya Therapeutics Q4 EPS $(0.12) Beats $(0.13) Estimate
Reuters·03/11 20:08
Tenaya Therapeutics Q4 net loss narrows 15% to USD 20.18 million
Dow Jones·03/11 20:07
*Tenaya Therapeutics Sees Extending Cash Runway Into 2H of 2027 >TNYA
Same Industry
Name/Symbol
Change%
Price